S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
BABA   205.03 (-1.78%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
BABA   205.03 (-1.78%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
BABA   205.03 (-1.78%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
BABA   205.03 (-1.78%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
GILD   72.66 (-2.73%)
Log in

NYSE:HUM - Humana Stock Price, Forecast & News

$314.33
-14.34 (-4.36 %)
(As of 02/27/2020 04:00 PM ET)
Today's Range
$312.45
Now: $314.33
$325.98
50-Day Range
$332.02
MA: $360.29
$380.20
52-Week Range
$225.65
Now: $314.33
$384.99
Volume1.48 million shs
Average Volume1.08 million shs
Market Capitalization$41.52 billion
P/E Ratio15.65
Dividend Yield0.67%
Beta0.95
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. Read More…

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.89 billion
Cash Flow$21.31 per share
Book Value$91.12 per share

Profitability

Net Income$2.71 billion

Miscellaneous

Employees41,600
Market Cap$41.52 billion
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.


Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Friday, February 21st. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.625 per share on Friday, April 24th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date of this dividend is Monday, March 30th. This is a boost from Humana's previous quarterly dividend of $0.55. View Humana's Dividend History.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) released its quarterly earnings data on Wednesday, February, 5th. The insurance provider reported $2.28 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.20 by $0.08. The insurance provider had revenue of $16.30 billion for the quarter, compared to the consensus estimate of $16.15 billion. Humana had a return on equity of 20.89% and a net margin of 4.17%. The business's quarterly revenue was up 15.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.65 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana updated its FY20 earnings guidance on Wednesday, February, 5th. The company provided earnings per share (EPS) guidance of $18.25-18.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $18.63.

What price target have analysts set for HUM?

17 analysts have issued 12-month target prices for Humana's stock. Their forecasts range from $290.00 to $460.00. On average, they expect Humana's stock price to reach $384.00 in the next twelve months. This suggests a possible upside of 22.2% from the stock's current price. View Analyst Price Targets for Humana.

What is the consensus analysts' recommendation for Humana?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

Has Humana been receiving favorable news coverage?

News stories about HUM stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Humana earned a coverage optimism score of -1.7 on InfoTrie's scale. They also gave news stories about the insurance provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Humana.

Are investors shorting Humana?

Humana saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 2,170,000 shares, an increase of 12.4% from the January 30th total of 1,930,000 shares. Based on an average daily volume of 985,400 shares, the short-interest ratio is presently 2.2 days. Currently, 1.7% of the company's stock are sold short. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), Alibaba Group (BABA), NVIDIA (NVDA), Walt Disney (DIS), Mastercard (MA), Visa (V), Boeing (BA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51)

Who are Humana's major shareholders?

Humana's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Capital International Investors (7.58%), Capital Research Global Investors (5.91%), FMR LLC (4.71%), State Street Corp (4.36%), Capital World Investors (3.92%) and Renaissance Technologies LLC (2.23%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including GQG Partners LLC, Ceredex Value Advisors LLC, Maverick Capital Ltd., Janus Henderson Group PLC, Marshall Wace North America L.P., Marshall Wace LLP, FMR LLC and Point72 Asset Management L.P.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley and Timothy S Huval. View Insider Buying and Selling for Humana.

Which institutional investors are buying Humana stock?

HUM stock was bought by a variety of institutional investors in the last quarter, including Capital Research Global Investors, AQR Capital Management LLC, Man Group plc, Capital World Investors, Boston Partners, First Trust Advisors LP, Panagora Asset Management Inc. and Schroder Investment Management Group. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $314.33.

How big of a company is Humana?

Humana has a market capitalization of $41.53 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 41,600 workers across the globe.View Additional Information About Humana.

What is Humana's official website?

The official website for Humana is http://www.humana.com/.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  779 (Vote Outperform)
Underperform Votes:  811 (Vote Underperform)
Total Votes:  1,590
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel